arBtrage CAPITALIZING MARKETS checking… Sign in

Tyra Biosciences, Inc.

TYRA Health Care Biotechnology: Pharmaceutical Preparations
$26.64
▼ -2.0% Today
as of Jun 7, 07:30 ET
Last 30 days -24.02% Apr 28 → Jun 05
$25.81 $28.82 $31.84 $34.86 $37.87 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$27.11
High
$27.79
Low
$26.41
Volume
$1M
Avg Vol
$587,700
Mkt Cap
$1.9B
P/E (TTM)
Beta
52w High
$40.65
52w Low
$8.98
Div Yield
Shares Out
$59M

Overview

52-week range
$8.98
$41
56% of range
Avg surprise (last 2)
-1.3%
Avg reaction (last 2)
+7.0%
100% positive
Latest IV / EM
176%
EM ±24.4% · $25 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.64$-0.56$-0.47$-0.39$-0.31 Actual $-0.31Actual $-0.49Actual $-0.35Actual $-0.32Actual $-0.41Actual $-0.47Est $-0.49Actual $-0.47Actual $-0.50Actual $-0.64Est $-0.60 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-39M$-34M$-29M$-25M$-20M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.64 $-0.60 -6.7% -36.2% +3.8% earnings
Tue Sep 30, 2025Sep 2025 $-0.50 financials
Mon Jun 30, 2025Jun 2025 $-0.47 financials
Thu May 8, 2025Mar/2025 $-0.47 $-0.49 +4.1% +10.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.41 financials
Sun Jun 30, 2024Jun 2024 $-0.32 financials
Sun Mar 31, 2024Mar 2024 $-0.35 financials
Sat Sep 30, 2023Sep 2023 $-0.49 financials
Fri Jun 30, 2023Jun 2023 $-0.31 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-42M$-33M$-31M$-32M$-29M$-24M
Net income$-39M$-30M$-28M$-28M$-24M$-19M
EPS (diluted)$-0.64$-0.50$-0.47$-0.47$-0.41$-0.32

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$85M$77M$62M$98M$101M$92M$104M$99M
Inventory
Total current assets$395M$265M$281M$302M$325M$347M$366M$379M
Total assets$412M$283M$302M$321M$343M$364M$381M$392M
Long-term debt
Total liabilities$24M$23M$21M$19M$20M$20M$18M$16M
Total equity$388M$259M$281M$302M$324M$343M$362M$376M

Implied volatility — last 90 days

171%173%176%178%181% Jun 07 — IV 176% · EM ±24.4%

Sector peers